About Careers MedBlog Contact us

Improved Diagnostics for Tuberculosis Under-Developed in India: Experts

by Bidita Debnath on June 2, 2015 at 10:57 AM
Font : A-A+

Improved Diagnostics for Tuberculosis Under-Developed in India: Experts

India needs advanced diagnostics to combat tuberculosis (TB) early and accurately in the wake of drug resistance, an expert said, adding that several such systems are under development.

The need of the hour is point-of-care tests (POCT) which essentially brings the tests to the suspected person, increasing the likelihood of faster detection and quick initiation of management strategies, said Indian microbiologist N.K. Ganguly.


"If we can improve POCT and bring in sensitive, inexpensive methods, then it will be a great help," Ganguly, the former director general of the Indian Council of Medical Research (ICMR) said.

He said tests such as GeneXpert MTB/RIF, LAM urinary test and LED microscopy with auramine staining are under evaluation.

The GeneXpert MTB/RIF, which diagnoses the disease by detecting the presence of TB bacteria, as well as testing for resistance to the drug Rifampicin, is in introduction stage. It uses sputum sample and can give a result in less than two hours.

"All of them are under evaluation. However, the GeneXpert is in introduction stage and LED microscopy has been recommended by the WHO in 2011 to be used. These tests are essential for TB but some common platforms could be used for HIV also," said Ganguly, a visiting professor at the Translational Health Science and Technology Institute, an autonomous institute of the department of biotechnology under the union science and technology ministry.

In addition, he advocated better management in therapy since some patients, who experience initial reactions to drugs, turn away from the treatment which is a major issue, compounding the problem of drug resistance.

Ganguly, along with a group of global health experts including from Medecins Sans Frontiers (MSF) and the Drugs for Neglected Diseases initiative (DNDi), has called for the creation of a global health research and development fund and mechanism to address deadly gaps in innovation for emerging infectious diseases such as Ebola, anti-microbial resistance, and a host of other diseases that have been neglected by the pharmaceutical market.

The essay was published in the PLOS Medicine journal dated May 11.

Source: IANS


Recommended Reading

Latest Diet & Nutrition News

Behind the Label: The Avocado Oil Deception
Study has revealed that despite the rising popularity of avocado oil, nearly 70% of private-label avocado oil is found to be rancid and adulterated with other oils.
Shrinking Plates, Expanding Benefits!
Impact of plate size on meal intake and weight loss efforts is underscored by experts as they advocate for the benefits of choosing smaller plates.
Cool Down With Watermelon This Summer!
Experts have shared common and easy ways to relish watermelon this summer. Read on to find how.
How Does a Skin Patch Help Toddlers With Peanut Allergy?
A recently developed skin patch was found to protect kids with peanut allergies, revealed clinical trial results.
 Very Low Carbohydrate Diets Keep Blood Pressure, Blood Sugar, and Weight in Control
New study highlights the recommended dietary patterns and support strategies for individuals with hypertension, prediabetes or type 2 diabetes, and obesity.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Improved Diagnostics for Tuberculosis Under-Developed in India: Experts Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests